Microsoft cuts first-quarter intelligent cloud revenue forecast-June 2024-www.financetom.com

Microsoft cuts first-quarter intelligent cloud revenue forecast

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Microsoft cuts first-quarter intelligent cloud revenue forecast

Aug 22, 2024 1:15 PM

Aug 21 (Reuters) - Microsoft ( MSFT ) on Wednesday cut

its first-quarter intelligent cloud forecast, the technology

giant said in an investor presentation.

The company now expects intelligent cloud revenue to be

between $23.80 billion and $24.10 billion, compared with its

prior expectations of $28.6 billion and $28.9 billion.

(Reporting by Jaspreet Singh in Bengaluru; Editing by Arun

Koyyur)

Previous page： Montrose Environmental Acquires Canada-based Paragon Soil & Environmental Consulting Next page： Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Montrose Environmental Acquires Canada-based Paragon Soil & Environmental Consulting

Jun 5, 2024

08:25 AM EDT, 06/05/2024 (MT Newswires) -- Montrose Environmental Group ( MEG ) said Wednesday that it has acquired Paragon Soil & Environmental Consulting, a Canada-based environmental consulting firm. Financial terms of the deal were not disclosed. Price: 43.54, Change: -0.43, Percent Change: -0.98 ...

Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories

Jun 5, 2024

08:27 AM EDT, 06/05/2024 (MT Newswires) -- Axsome Therapeutics ( AXSM ) said Wednesday it has settled patent litigation with Unichem Laboratories regarding Axsome's sleep disorder drug Sunosi. The pharmaceutical company said the litigation, pending in the United States District Court for the District of New Jersey, arose after Unichem applied for the US Food and Drug Administration's approval to...

Mind Medicine Shares Fall After FDA Committee Votes Against Lykos Therapeutics' Psychedelic Drug

Jun 5, 2024

08:25 AM EDT, 06/05/2024 (MT Newswires) -- Mind Medicine's (MNMD) shares were down 9% in Wednesday's premarket activity, a day after advisers to the US Food and Drug Administration voted against Lykos Therapeutics' psychedelic drug. Lykos Therapeutics said late Tuesday that advisers to the US Food and Drug Administration have voted against its therapy based on the mind-altering drug midomafetamine,...

Calibre Reports Additional Gold Mineralization at Valentine Gold Mine Complex in Newfoundland & Labrador

Jun 5, 2024

08:26 AM EDT, 06/05/2024 (MT Newswires) -- Calibre (CXB.TO), which lost 4% yesterday, on Wednesday highlighted drill results from its 2024 exploration program within its 250-square-kilometer Valentine Gold Mine complex in Newfoundland & Labrador, Canada. Among the highlights, the company reported 2.25 g/t of gold over 15.30 meters estimated true width, including 24.68 g/t of gold over 0.85 meters estimated...